Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Endocrinology

Biology, Causes, and Subtypes

At a Glance

Panhypophysitis is inflammation of the entire pituitary gland and its stalk. It may be autoimmune or secondary to immune checkpoint drugs, systemic inflammatory disease, infection, or a cyst, while cancer spread can mimic it. Diagnosis uses medical history, hormone tests, MRI, and sometimes biopsy.

While “panhypophysitis” describes the location of your inflammation (affecting the entire pituitary and its stalk), it does not tell the whole story of why the inflammation started. Doctors categorize this condition into “primary” and “secondary” types based on the biological trigger and the specific types of cells involved [1][2].

It is important to note that the specific subtype usually cannot be assigned confidently from age, sex, symptoms, or MRI alone. A definitive diagnosis often requires careful evaluation of your full medical history, blood tests, and sometimes a tissue biopsy.

Primary (Autoimmune) Subtypes

Primary hypophysitis occurs when the immune system targets the pituitary gland directly without an obvious outside cause.

  • Lymphocytic Hypophysitis: This is the most common primary form. It is characterized by an invasion of lymphocytes (a type of white blood cell) [3]. It predominantly affects women and is famously associated with the late stages of pregnancy or the first few months after giving birth (postpartum) [4][5].
  • Granulomatous Hypophysitis: This is a very rare form of the disease [6]. It involves the formation of granulomas (small clusters of immune cells) and “giant cells” [7]. It may cause significant clinical symptoms [5].
  • IgG4-Related Hypophysitis: This subtype is part of a larger, body-wide inflammatory condition called IgG4-related disease [8]. It most commonly affects older men and often involves other organs, such as the pancreas or salivary glands [8]. While a blood test for IgG4 levels can be helpful, some patients have normal blood levels even when the disease is present in the pituitary, so systemic evaluation and tissue confirmation is often required [9].

Secondary Causes: Medication Triggers

A “secondary” cause means the inflammation is a reaction to something else happening in your body. In recent years, a major cause of secondary hypophysitis has been a group of cancer treatments called Immune Checkpoint Inhibitors (ICIs) [10].

These drugs work by “releasing the brakes” on your immune system so it can attack cancer cells. Sometimes, this causes the immune system to attack the pituitary instead [11].

  • High-Risk Drugs: Drugs that block the CTLA-4 pathway (such as ipilimumab) carry the highest risk, especially when used in combination with other immunotherapies [12][13]. These often cause visible swelling on an MRI and multiple hormone deficiencies [14][15].
  • PD-1/PD-L1 Inhibitors: Drugs blocking this pathway have a lower risk and behave differently [12]. They often cause an “isolated” loss of ACTH (the hormone that controls cortisol) and may show a completely normal MRI, making them harder to detect without specific blood tests [16][17].

Other Secondary Causes and Mimics

Sometimes, panhypophysitis is a “hitchhiker” alongside another systemic disease, or mimicked by a local issue near the brain:

  • Systemic Inflammatory Diseases: Conditions like sarcoidosis, histiocytosis, or Crohn’s disease can cause secondary inflammation in the pituitary [18][9].
  • Infections and Cysts: A nearby Rathke’s cleft cyst or a localized infection can trigger an inflammatory response that mimics primary panhypophysitis [19][20].
  • Malignancy Mimics: Pituitary or stalk metastasis (spread of cancer, such as melanoma) must be carefully considered, especially when there are severe mass-effect symptoms and diabetes insipidus, which are less typical of ICI-related hypophysitis alone. In children, a tumor called a germinoma can also initially look like inflammation [21].

Identifying whether your condition is isolated to the pituitary or part of a systemic disease (like IgG4-related disease) ensures that your doctors are monitoring the right parts of your body for future flare-ups [9][11].

Common questions in this guide

What does panhypophysitis mean?
Panhypophysitis means inflammation involving the entire pituitary gland and the stalk connecting it to the brain. The word describes where the inflammation is, not why it started, so doctors still need to investigate the cause.
How are primary and secondary hypophysitis different?
Primary hypophysitis happens when the immune system attacks the pituitary directly, usually without an obvious outside trigger. Secondary hypophysitis is linked to another cause, such as immune checkpoint inhibitor treatment, a systemic inflammatory disease, an infection, or a nearby cyst.
Can cancer immunotherapy cause hypophysitis?
Yes. Immune checkpoint inhibitors can cause the immune system to inflame the pituitary; CTLA-4 medicines such as ipilimumab carry the highest risk, especially in combination therapy. PD-1 or PD-L1 medicines have a lower risk but may cause loss of ACTH, the hormone that helps control cortisol, even when the MRI looks normal.
Does a normal MRI rule out hypophysitis?
No. Hypophysitis related to PD-1 or PD-L1 medicines may cause an isolated ACTH and cortisol problem without visible pituitary swelling. Blood tests and the treatment history can therefore be important even when the MRI is normal.
What other conditions can look like panhypophysitis?
Cancer spread to the pituitary or stalk, infection, and a Rathke's cleft cyst can resemble pituitary inflammation. In children, germinoma can also look similar, and systemic diseases such as sarcoidosis, histiocytosis, or Crohn's disease can involve the pituitary. Doctors may use medical history, blood tests, imaging, and sometimes a biopsy to distinguish these possibilities.
Is hypophysitis associated with pregnancy or childbirth?
Lymphocytic hypophysitis is more common in women and is associated with late pregnancy or the first few months after giving birth. Pregnancy or recent childbirth can provide an important clue, but it cannot by itself confirm the subtype. Doctors also consider symptoms, hormone tests, imaging, and sometimes biopsy.
What is IgG4-related hypophysitis?
It is pituitary inflammation that occurs as part of IgG4-related disease, which can affect several organs, including the pancreas and salivary glands. It is most common in older men. A normal blood IgG4 level does not exclude it, so doctors may need to assess other organs and sometimes confirm the diagnosis with tissue.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which subtype of hypophysitis do you suspect I have, and what evidence points toward that specific type?
  2. 2.If my diagnosis is 'secondary,' what other conditions should we be screening for in the rest of my body?
  3. 3.For those on immune checkpoint inhibitors: Since my MRI is normal, how often will we monitor my ACTH and cortisol levels?
  4. 4.Could my symptoms and MRI findings be caused by a metastasis or another condition rather than inflammation?
  5. 5.Is there any chance my condition is related to a hidden infection or a nearby cyst that could be treated differently?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Neuroimaging of hypophysitis: etiologies and imaging mimics.

    Kurokawa R, Kurokawa M, Baba A, et al.

    Japanese journal of radiology 2023; (41(9)):911-927 doi:10.1007/s11604-023-01417-y.

    PMID: 37010787
  2. 2

    Executive summary of the consensus document on hypophysitis of the Neuroendocrinology Area of Knowledge of the Spanish Society of Endocrinology and Nutrition.

    Iglesias P, Biagetti B, Guerrero-Pérez F, et al.

    Endocrinologia, diabetes y nutricion 2023; (70 Suppl 1()):116-125 doi:10.1016/j.endien.2023.01.001.

    PMID: 36894450
  3. 3

    Granulomatous and lymphocytic hypophysitis - are they immunologically distinct?

    Rao S, Mahadevan A, Maiti T, et al.

    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016; (124(12)):1072-1077 doi:10.1111/apm.12603.

    PMID: 27704605
  4. 4

    Hypophysitis (Including IgG4 and Immunotherapy).

    Angelousi A, Alexandraki K, Tsoli M, et al.

    Neuroendocrinology 2020; (110(9-10)):822-835 doi:10.1159/000506903.

    PMID: 32126548
  5. 5

    Diagnosis of Primary Hypophysitis in Germany.

    Honegger J, Schlaffer S, Menzel C, et al.

    The Journal of clinical endocrinology and metabolism 2015; (100(10)):3841-9 doi:10.1210/jc.2015-2152.

    PMID: 26262437
  6. 6

    Idiopathic granulomatous hypophysitis: A report of an uncommon disorder.

    Agale SV, Binayke R, Kumari G, D'Costa GF

    Indian journal of pathology & microbiology 2018; (61(3)):389-392 doi:10.4103/IJPM.IJPM_77_17.

    PMID: 30004061
  7. 7

    [Hypophysitis : Types and differential diagnosis].

    Saeger W

    Der Pathologe 2016; (37(3)):230-7 doi:10.1007/s00292-016-0164-x.

    PMID: 27103256
  8. 8

    Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature.

    Uccella S, Amaglio C, Brouland JP, et al.

    Virchows Archiv : an international journal of pathology 2019; (475(3)):373-381 doi:10.1007/s00428-019-02564-2.

    PMID: 30911814
  9. 9

    Co-Occurrence of Craniopharyngioma and IgG4-Related Hypophysitis: An Epiphenomenon or a Mere Coincidence?

    Pal R, Chatterjee D, Singla R, et al.

    World neurosurgery 2020; (136()):193-197 doi:10.1016/j.wneu.2019.12.181.

    PMID: 31927125
  10. 10

    Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment.

    Di Dalmazi G, Ippolito S, Lupi I, Caturegli P

    Expert review of endocrinology & metabolism 2019; (14(6)):381-398 doi:10.1080/17446651.2019.1701434.

    PMID: 31842671
  11. 11

    Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management.

    Kotwal A

    Current opinion in endocrinology, diabetes, and obesity 2021; (28(4)):427-434 doi:10.1097/MED.0000000000000652.

    PMID: 34183541
  12. 12

    Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.

    Barroso-Sousa R, Barry WT, Garrido-Castro AC, et al.

    JAMA oncology 2018; (4(2)):173-182 doi:10.1001/jamaoncol.2017.3064.

    PMID: 28973656
  13. 13

    Risk of Pituitary Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

    Li Z, Liu Z, Wei H, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025; (31(9)):1177-1184 doi:10.1016/j.eprac.2025.06.008.

    PMID: 40532761
  14. 14

    Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced Hypophysitis.

    Quandt Z, Kim S, Villanueva-Meyer J, et al.

    Journal of the Endocrine Society 2023; (7(4)):bvad012 doi:10.1210/jendso/bvad012.

    PMID: 36860908
  15. 15

    MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.

    Kurokawa R, Ota Y, Gonoi W, et al.

    AJNR. American journal of neuroradiology 2020; (41(9)):1683-1689 doi:10.3174/ajnr.A6692.

    PMID: 32763900
  16. 16

    [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].

    Gu YC, Liu Y, Xie C, Cao BS

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2022; (54(2)):369-375.

    PMID: 35435206
  17. 17

    Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Diagnosis and Management.

    SirDeshpande P, Hegde SBS, Akhtar H

    Cureus 2025; (17(12)):e98717 doi:10.7759/cureus.98717.

    PMID: 41510421
  18. 18

    A Remarkable Response of Granulomatous Hypophysitis to Infliximab in a Patient With a Background of Crohn's Disease-A Case Report.

    Force BK, Vogel TP, Nguyen DM, et al.

    Frontiers in endocrinology 2020; (11()):350 doi:10.3389/fendo.2020.00350.

    PMID: 32547497
  19. 19

    Clinical features of Rathke's cleft cyst with secondary hypophysitis and outcomes of endoscopic transnasal surgery versus features of common Rathke's cleft cysts: a single-center retrospective cohort study.

    Ehara T, Fukuhara N, Ito S, et al.

    Journal of neurosurgery 2025; (143(2)):423-430 doi:10.3171/2025.1.JNS24892.

    PMID: 40279717
  20. 20

    Rare secondary pituitary abscess arising in a craniopharyngioma: A case report and literature review.

    Fan R, Zhao R, Zhong Y, Wan W

    Experimental and therapeutic medicine 2025; (30(2)):158 doi:10.3892/etm.2025.12908.

    PMID: 40599421
  21. 21

    Intracranial Germinoma Masquerading as Secondary Granulomatous Hypophysitis: A Case Report and Review of Literature.

    Pal R, Rai A, Vaiphei K, et al.

    Neuroendocrinology 2020; (110(5)):422-429 doi:10.1159/000501886.

    PMID: 31269501

This page is for informational purposes only and does not constitute medical advice. Your endocrinologist and other treating clinicians should interpret your tests and determine the cause of your pituitary inflammation.

Get notified when new evidence is published on Panhypophysitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.